The escalating Bundibugyo Ebola outbreak: A renewed imperative for global health security
Clinical Epidemiology and Global Health · 2026-09 · 41 · 102425
DOI: 10.1016/j.cegh.2026.102425 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Epidemiology and Global Health, 2026-09. Verfasst von Abdullahi Osman Mohamed und 4 weiteren Autor:innen. Die Arbeit nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The ongoing Bundibugyo ebolavirus outbreak represents a serious and evolving threat to global health security, underscoring persistent weaknesses in outbreak preparedness, early detection, and response systems in fragile settings. Ebola virus disease remains one of the most severe viral hemorrhagic fevers, with high epidemic potential and significant mortality risk when not rapidly contained[1]. Recent outbreak reports from the World Health Organization indicate sustained transmission in affected regions of Central Africa, highlighting ongoing challenges in achieving timely containment and strengthening regional preparedness efforts [2].
Zitieren
APA
Mohamed, A. O., Afyare, A., Abdi, A. M., Muhumed, Y. H., & Abdihashi, M. A. (2026). The escalating Bundibugyo Ebola outbreak: A renewed imperative for global health security. Clinical Epidemiology and Global Health, 41, 102425. https://doi.org/10.1016/j.cegh.2026.102425
Vancouver
Mohamed AO, Afyare A, Abdi AM, Muhumed YH, Abdihashi MA. The escalating Bundibugyo Ebola outbreak: A renewed imperative for global health security. Clinical Epidemiology and Global Health. 2026;41:102425. doi:10.1016/j.cegh.2026.102425
BibTeX
@article{Mohamed2026,
author = {Mohamed, Abdullahi Osman and Afyare, Abdifatah and Abdi, Abdinasir Mohamed and Muhumed, Yusuf Hassan and Abdihashi, Mohamed Adam},
title = {The escalating Bundibugyo Ebola outbreak: A renewed imperative for global health security},
journal = {Clinical Epidemiology and Global Health},
year = {2026},
volume = {41},
pages = {102425},
doi = {10.1016/j.cegh.2026.102425}
}
EUVIMED